Loading...
Pharmaceutical-grade research compounds
Buy tissue-repair and recovery research peptides online — BPC-157, TB-500 (Thymosin Beta-4), KPV, and SLU-PP-332 — all HPLC-verified at ≥99% purity with full Certificate of Analysis. This category is the frontier of regenerative-medicine research. BPC-157 is a 15-amino-acid peptide derived from human gastric juice, demonstrating accelerated tendon, ligament, muscle, bone and gut epithelium healing in animal models through growth-factor upregulation (EGF, FGF, VEGF, NGF) and nitric-oxide modulation. TB-500 (Thymosin Beta-4) is a 43-amino-acid peptide found in virtually all human cells, central to cell migration and cardiac, muscle and neural tissue repair via actin-binding and angiogenic mechanisms. Researchers frequently combine BPC-157 and TB-500 protocols, as they act through complementary pathways — BPC-157 modulating growth-factor signalling and TB-500 facilitating cell migration to injury sites. KPV delivers localised anti-inflammatory research applications, while SLU-PP-332 is an emerging exercise-mimetic compound for metabolic and muscle-recovery investigation. Every compound is supplied at pharmaceutical research-grade purity with complete analytical documentation, suitable for wound-healing, tendon-repair, neuroprotection, inflammation and systemic tissue-regeneration models. Pre-assembled Wolverine and Recomp stacks bundle BPC-157 with TB-500 at protocol-aligned vial sizes.
BPC-157 is a 15-amino-acid peptide derived from human gastric juice. Animal studies demonstrate accelerated healing across multiple tissue types: tendons, ligaments, muscle, bone, and gut epithelium. Its mechanism involves upregulation of growth factors (EGF, FGF, VEGF) and nitric oxide system modulation.
TB-500 is a synthetic fragment of Thymosin Beta-4, a 43-amino-acid peptide found in virtually all human cells. Research shows it promotes cell migration, reduces inflammation, and supports cardiac and muscle tissue repair through actin-binding and angiogenic mechanisms.
Both BPC-157 and TB-500 show neuroprotective properties in animal models. BPC-157 research demonstrates protection against various neurotoxic insults, while TB-500 promotes neural cell survival and reduces neuroinflammation — opening pathways for neurodegenerative disease research.
Researchers frequently study BPC-157 and TB-500 in combination, as they work through complementary mechanisms. BPC-157 primarily modulates growth factor signaling, while TB-500 facilitates cell migration to injury sites — potentially producing additive repair responses.
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. The synthetic version is a stable fragment that retains the parent compound's biological activity in research models.
Yes, many research protocols study these compounds in combination. They work through different mechanisms — BPC-157 via growth factor and NO modulation, TB-500 via actin binding and cell migration — making them complementary research tools.
Animal studies have investigated BPC-157's effects on tendons, ligaments, muscles, bones, gut epithelium, liver tissue, corneal tissue, and neural tissue. It shows broad-spectrum tissue protective properties across these models.
No products found.